ICP-OES spectrometer market seen reaching $1.82 billion by 2030

The ICP-OES spectrometer market is projected to grow from $1.32 billion in 2025 to $1.41 billion in 2026, with further expansion to $1.82 billion by 2030. Growth is being driven by pharmaceutical and biotechnology investment, industrial automation, and rising demand for elemental analysis in research, food safety, and environmental testing.

Why it matters: - ICP-OES spectrometers are central to elemental analysis in pharmaceuticals, biotechnology, environmental monitoring, food safety and industrial quality control. - The market’s projected growth points to broader spending on laboratory equipment, automation and analytical precision. - The report frames the sector as one that benefits from tighter regulation and expanding R&D activity across multiple industries.

What happened: - The Business Research Company released a market report on the global ICP-OES spectrometer market. - The report estimates market value will rise from $1.32 billion in 2025 to $1.41 billion in 2026. - The report forecasts the market will reach $1.82 billion by 2030. - The report projects a 6.9% CAGR from 2025 to 2026 and a 6.6% CAGR through 2030. - The company published a free sample report and the full market report.

The details: - ICP-OES stands for inductively coupled plasma optical emission spectrometer. - The instrument identifies and quantifies elemental concentrations in samples by using high-temperature plasma and measuring emitted light at specific wavelengths. - The report cites expanding applications in analytical chemistry, scientific research, plasma-based spectrometry, academic and research laboratories and environmental monitoring as current growth drivers. - The report points to future growth from better sensitivity and resolution, stronger pharmaceutical and biotechnology research, stricter food safety rules, wider nanotechnology use and more laboratory automation. - Expected product trends include more demand for multi-element analysis, broader use of high-resolution and simultaneous ICP-OES instruments, more environmental and food testing use, and growth in compact and benchtop systems. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report ties market growth to sectors that are spending more on R&D and stricter compliance, which usually increases demand for precise testing tools. - Industrial automation is becoming a bigger tailwind because manufacturers want faster and more repeatable elemental analysis in production settings. - The geographic split suggests the market is already mature in North America, while growth is shifting toward regions with expanding industrial and regulatory activity. - The report says health sector R&D investments reached about $297.79 billion (€258 billion) in 2023, equal to 20.5% of total global business R&D expenditure, citing EFPIA. - The report says industrial robot installations rose 51% in the UK to 3,830 units, and Americas robot installations reached 55,389 units in 2023, citing IFR.

What's next: - The report expects continued demand from pharmaceutical and biotechnology research, food safety testing, environmental monitoring and lab automation. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and future trend analysis. - The market’s next phase will likely be shaped by instrument sensitivity gains and broader adoption of compact, automated systems.

The bottom line: - ICP-OES spectrometry is moving from a specialized lab tool to a broader industrial and regulatory workhorse, with steady growth expected through 2030.